Money · Lobbying reports · 119th Congress
S. 2730
14 saved lobbying reports name S. 2730.
14 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 11:24 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| VENABLE LLP | AMERICAN NEPHROLOGY NURSES ASSOCIATION | $30,000.00reported as income | April to June 2026 | Open the report |
| CROSSROADS STRATEGIES, LLC | KIDNEY CARE PARTNERS | $70,000.00reported as income | April to June 2026 | Open the report |
| THE FERRARO GROUP | THE ROGOSIN INSTITUTE | $30,000.00reported as income | April to June 2026 | Open the report |
| MEHLMAN CONSULTING, INC. | RENAL HEALTHCARE ASSOCIATION | $70,000.00reported as income | April to June 2026 | Open the report |
| FRESENIUS MEDICAL CARE NORTH AMERICA | FRESENIUS MEDICAL CARE NORTH AMERICA | $1,190,000.00reported as expenses | April to June 2026 | Open the report |
| JEFFREY J. KIMBELL & ASSOCIATES, INC. | U.S. RENAL CARE | $50,000.00reported as income | April to June 2026 | Open the report |
| FEDERAL HEALTH POLICY STRATEGIES | KIDNEY CARE PARTNERS | $80,000.00reported as income | April to June 2026 | Open the report |
| AVENUE SOLUTIONS | FRESENIUS MEDICAL CARE NORTH AMERICA | $60,000.00reported as income | April to June 2026 | Open the report |
| DAVITA INC. | DAVITA INC | $980,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN KIDNEY FUND | AMERICAN KIDNEY FUND | $240,000.00reported as expenses | April to June 2026 | Open the report |
| DIALYSIS PATIENT CITIZENS | DIALYSIS PATIENT CITIZENS | $500,000.00reported as expenses | April to June 2026 | Open the report |
| AKEBIA THERAPEUTICS, INC. | AKEBIA THERAPEUTICS, INC. | $360,000.00reported as expenses | April to June 2026 | Open the report |
| CORMEDIX INC. | CORMEDIX INC. | $220,000.00reported as expenses | April to June 2026 | Open the report |
| LESTER HEALTH LAW PLLC | U.S. RENAL CARE | $23,000.00reported as income | April to June 2026 | Open the report |